Overview

A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

Status:
Completed

Trial end date:
2004-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the effectiveness of early treatment of anemia with epoetin alfa (a glycoprotein that stimulates red blood cell production) or best standard anemia care on the need for blood transfusions, tumor response, anemia and quality of life in patients with cancer receiving platinum-containing chemotherapy.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen-Cilag B.V.

Treatments:

Epoetin Alfa